Insomnia Treatment Market Segmented By OTC drugs and Prescription Drugs in Hospital Pharmacies, Retail Pharmacies, E-commerce and Drug Stores, hypermarkets
Industry: Healthcare
Published Date: June-2018
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 163
Report ID: PMRREP23203
1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
2.3. Inclusion and Exclusion
3. Market Dynamics
3.1. Macro-Economic Factors
3.2. Drivers
3.3. Restraints
3.4. Opportunity Analysis
3.5. Trends
4. Macroeconomic Assumptions
5. Global Economic Outlook
5.1. Gross Domestic Product by Region & Country, 2006 – 2021
5.2. Healthcare Sector Outlook
5.3. Healthcare Indicators
6. Key Inclusions
6.1. Epidemiology of Insomnia, By Region
7. North America Insomnia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
7.1. Introduction
7.2. Regional Market Trends
7.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
7.3.1. U.S.
7.3.2. Canada
7.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
7.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
7.5.1. OTC Drugs
7.5.1.1. OTC Sleep Aids
7.5.1.2. OTC Sleep Supplements
7.5.2. Prescription Drugs
7.6. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
7.7. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
7.7.1. Hospital Pharmacies
7.7.2. Retail Pharmacies
7.7.3. e commerce
7.7.4. Drug Stores
7.7.5. Others
7.8. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
7.9. Market Attractiveness Analysis
7.9.1. By Country
7.9.2. By Drug Type
7.9.3. By Distribution Channel
8. Latin America Insomnia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
8.1. Introduction
8.2. Regional Market Trends
8.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
8.3.1. Argentina
8.3.2. Brazil
8.3.3. Mexico
8.3.4. Rest of Latin America
8.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
8.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
8.5.1. OTC Drugs
8.5.1.1. OTC Sleep Aids
8.5.1.2. OTC Sleep Supplements
8.5.2. Prescription Drugs
8.6. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
8.7. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
8.7.1. Hospital Pharmacies
8.7.2. Retail Pharmacies
8.7.3. e commerce
8.7.4. Drug Stores
8.7.5. Others
8.8. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
8.9. Market Attractiveness Analysis
8.9.1. By Country
8.9.2. By Drug Type
8.9.3. By Distribution Channel
9. Europe Insomnia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
9.1. Introduction
9.2. Regional Market Trends
9.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Italy
9.3.5. Spain
9.3.6. Russia
9.3.7. Poland
9.3.8. Rest of Europe
9.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
9.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
9.5.1. OTC Drugs
9.5.1.1. OTC Sleep Aids
9.5.1.2. OTC Sleep Supplements
9.5.2. Prescription Drugs
9.6. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
9.7. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
9.7.1. Hospital Pharmacies
9.7.2. Retail Pharmacies
9.7.3. e commerce
9.7.4. Drug Stores
9.7.5. Others
9.8. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
9.9. Market Attractiveness Analysis
9.9.1. By Country
9.9.2. By Drug Type
9.9.3. By Distribution Channel
10. Asia Pacific Insomnia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
10.1. Introduction
10.2. Regional Market Trends
10.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia and New Zealand
10.3.5. ASEAN
10.3.6. Rest of Asia Pacific
10.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
10.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
10.5.1. OTC Drugs
10.5.1.1. OTC Sleep Aids
10.5.1.2. OTC Sleep Supplements
10.5.2. Prescription Drugs
10.6. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
10.7. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
10.7.1. Hospital Pharmacies
10.7.2. Retail Pharmacies
10.7.3. e commerce
10.7.4. Drug Stores
10.7.5. Others
10.8. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
10.9. Market Attractiveness Analysis
10.9.1. By Country
10.9.2. By Drug Type
10.9.3. By Distribution Channel
11. Middle East & Africa Insomnia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
11.1. Introduction
11.2. Key Regulations
11.3. Historical Market Size (US$ Mn) Trend Analysis By Country, 2013–2017
11.3.1. GCC Countries
11.3.2. South Africa
11.3.3. Rest of MEA
11.4. Market Size (US$ Mn) Forecast By Country, 2018–2026
11.5. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
11.5.1. OTC Drugs
11.5.1.1. OTC Sleep Aids
11.5.1.2. OTC Sleep Supplements
11.5.2. Prescription Drugs
11.6. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
11.7. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
11.7.1. Hospital Pharmacies
11.7.2. Retail Pharmacies
11.7.3. e commerce
11.7.4. Drug Stores
11.7.5. Others
11.8. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
11.9. Market Attractiveness Analysis
11.9.1. By Country
11.9.2. By Drug Type
11.9.3. By Distribution Channel
12. Forecast Factors: Relevance and Impact
13. Competition Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Profitability and Gross Margin Analysis By Competition
13.4. Company Deep Dive
13.4.1. Merck & Co. Inc.
13.4.1.1. Overview
13.4.1.2. Product and Technology Portfolio
13.4.1.3. Production Footprint
13.4.1.4. Sales Footprint
13.4.1.5. Channel Footprint
13.4.1.6. Strategy
13.4.1.6.1. Marketing Strategy
13.4.1.6.2. Product Strategy
13.4.1.6.3. Channel Strategy
13.4.2. Natrol, LLC
13.4.2.1. Overview
13.4.2.2. Product and Technology Portfolio
13.4.2.3. Production Footprint
13.4.2.4. Sales Footprint
13.4.2.5. Channel Footprint
13.4.2.6. Strategy
13.4.2.6.1. Marketing Strategy
13.4.2.6.2. Product Strategy
13.4.2.6.3. Channel Strategy
13.4.3. GlaxoSmithKline Plc.
13.4.3.1. Overview
13.4.3.2. Product and Technology Portfolio
13.4.3.3. Production Footprint
13.4.3.4. Sales Footprint
13.4.3.5. Channel Footprint
13.4.3.6. Strategy
13.4.3.6.1. Marketing Strategy
13.4.3.6.2. Product Strategy
13.4.3.6.3. Channel Strategy
13.4.4. Sanofi SA
13.4.4.1. Overview
13.4.4.2. Product and Technology Portfolio
13.4.4.3. Production Footprint
13.4.4.4. Sales Footprint
13.4.4.5. Channel Footprint
13.4.4.6. Strategy
13.4.4.6.1. Marketing Strategy
13.4.4.6.2. Product Strategy
13.4.4.6.3. Channel Strategy
13.4.5. Pfizer Inc.
13.4.5.1. Overview
13.4.5.2. Product and Technology Portfolio
13.4.5.3. Production Footprint
13.4.5.4. Sales Footprint
13.4.5.5. Channel Footprint
13.4.5.6. Strategy
13.4.5.6.1. Marketing Strategy
13.4.5.6.2. Product Strategy
13.4.5.6.3. Channel Strategy
13.4.6. Boehringer Ingelheim International GmbH
13.4.6.1. Overview
13.4.6.2. Product and Technology Portfolio
13.4.6.3. Production Footprint
13.4.6.4. Sales Footprint
13.4.6.5. Channel Footprint
13.4.6.6. Strategy
13.4.6.6.1. Marketing Strategy
13.4.6.6.2. Product Strategy
13.4.6.6.3. Channel Strategy
13.4.7. Mallinckrodt
13.4.7.1. Overview
13.4.7.2. Product and Technology Portfolio
13.4.7.3. Production Footprint
13.4.7.4. Sales Footprint
13.4.7.5. Channel Footprint
13.4.7.6. Strategy
13.4.7.6.1. Marketing Strategy
13.4.7.6.2. Product Strategy
13.4.7.6.3. Channel Strategy
13.4.8. PERNIX Therapeutics
13.4.8.1. Overview
13.4.8.2. Product and Technology Portfolio
13.4.8.3. Production Footprint
13.4.8.4. Sales Footprint
13.4.8.5. Channel Footprint
13.4.8.6. Strategy
13.4.8.6.1. Marketing Strategy
13.4.8.6.2. Product Strategy
13.4.8.6.3. Channel Strategy
13.4.9. Takeda Pharmaceutical Company Limited
13.4.9.1. Overview
13.4.9.2. Product and Technology Portfolio
13.4.9.3. Production Footprint
13.4.9.4. Sales Footprint
13.4.9.5. Channel Footprint
13.4.9.6. Strategy
13.4.9.6.1. Marketing Strategy
13.4.9.6.2. Product Strategy
13.4.9.6.3. Channel Strategy
13.4.10. Sunovion Pharmaceuticals, Inc.
13.4.10.1. Overview
13.4.10.2. Product and Technology Portfolio
13.4.10.3. Production Footprint
13.4.10.4. Sales Footprint
13.4.10.5. Channel Footprint
13.4.10.6. Strategy
13.4.10.6.1. Marketing Strategy
13.4.10.6.2. Product Strategy
13.4.10.6.3. Channel Strategy
14. Global Insomnia Treatment Market Analysis 2013–2017 and Forecast 2018–2026, By Region
14.1. Introduction/Key Findings
14.2. Historical Market Size (US$ Mn)Trend Analysis By Region, 2013–2017
14.3. Market Size (US$ Mn) Forecast By Region, 2018–2026
14.3.1. North America
14.3.2. Latin America
14.3.3. Europe
14.3.4. Asia Pacific Excluding China
14.3.5. China
14.3.6. Middle East & Africa
14.4. Market Attractiveness Analysis By Region
15. Global Insomnia Treatment Analysis 2013–2017 and Forecast 2018–2026, By Drug Type
15.1. Introduction/Key Findings
15.2. Historical Market Size (US$ Mn) Trend Analysis By Drug Type, 2013–2017
15.2.1. OTC Drugs
15.2.1.1. OTC Sleep Aids
15.2.1.2. OTC Sleep Supplements
15.2.2. Prescription Drugs
15.3. Market Size (US$ Mn) Forecast By Drug Type, 2018–2026
15.4. Market Attractiveness Analysis By Drug Type
16. Global Insomnia Treatment Market Analysis 2013–2017 and Forecast 2018–2026, By Distribution Channel
16.1. Introduction/Key Findings
16.2. Historical Market Size (US$ Mn) Trend Analysis By Distribution Channel, 2013–2017
16.2.1. Hospital Pharmacies
16.2.2. Retail Pharmacies
16.2.3. e commerce
16.2.4. Drug Stores
16.2.5. Others
16.3. Market Size (US$ Mn) Forecast By Distribution Channel, 2018–2026
16.4. Market Attractiveness Analysis By Distribution Channel
17. Global Insomnia Treatment Market Analysis 2013–2017 and Forecast 2018–2026
17.1. Market Value Share Analysis
17.2. Y-o-Y Growth Analysis
17.3. Absolute $ Opportunity
18. Research Methodology
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Table 01: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 02: Expenditure on Health, (% of GDP), by Country, 2016 - 2021
Table 03: North America Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 04: North America Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
Table 05: North America Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 06: Latin America Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 07: Latin America Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
Table 08: Latin America Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 09: Europe Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 10: Europe Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
Table 11: Europe Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 12: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 13: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
Table 14: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 15: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Country
Table 16: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
Table 17: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Table 18: Global Sleep Aids Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Region
Table 19: Global Sleep Aids Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Drug Type
Table 20: Global Sleep Aids Size (US$ Mn) Analysis 2013-2017 and Forecast 2018-2026, By Distribution Channel
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
Figure 01: Country wise Prevalence of Insomnia, 2016
Figure 02: Percentage of adults aged 20 and over using prescription sleep aids, by age: United States, 2005–2010
Figure 03: Global Healthcare Expenditure in US$ Tn (2013–2020)
Figure 04: North America Insomnia Treatment Market Value Share (2017A), By Drug Type , Distribution Channel and Country
Figure 05: North America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
Figure 06: North America Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 07: North America Insomnia Treatment Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 08: U.S. Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 09: U.S. Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 10: Canada Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 11: Canada Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 12: North America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By OTC Drugs
Figure 13: North America Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By OTC Drugs
Figure 14: North America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Drugs
Figure 15: North America Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Prescription Drugs
Figure 16: North America Insomnia Treatment Market Attractiveness Analysis, By Country
Figure 17: North America Insomnia Treatment Market Attractiveness Analysis, By Drug Type
Figure 18: North America Insomnia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 19: Latin America Insomnia Treatment Market Value Share (2017A), By Drug Type , Distribution Channel and Country
Figure 20: Latin America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
Figure 21: Latin America Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 22: Latin America Insomnia Treatment Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 23: Brazil Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 24: Brazil Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 25: Mexico Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 26: Mexico Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 27: Rest of Latin America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 28: Rest of Latin America Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 29: Latin America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By OTC Drugs
Figure 30: Latin America Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By OTC Drugs
Figure 31: Latin America Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Drugs
Figure 32: Latin America Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Prescription Drugs
Figure 33: Latin America Insomnia Treatment Market Attractiveness Analysis, By Country
Figure 34: Latin America Insomnia Treatment Market Attractiveness Analysis, By Drug Type
Figure 35: Latin America Insomnia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 36: Europe Insomnia Treatment Market Value Share (2017A), By Drug Type , Distribution Channel and Country
Figure 37: Europe Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
Figure 38: Europe Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 39: Europe Insomnia Treatment Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 40: Germany Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 41: Germany Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 42: U.K. Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 43: U.K. Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 44: France Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 45: France Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 46: Italy Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 47: Italy Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 48: Spain Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 49: Spain Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 50: Russia Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 51: Russia Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 52: Poland Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 53: Poland Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 54: Rest of Europe Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 55: Rest of Europe Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 56: Europe Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By OTC Drugs
Figure 57: Europe Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By OTC Drugs
Figure 58: Europe Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Drugs
Figure 59: Europe Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Prescription Drugs
Figure 60: Europe Insomnia Treatment Market Attractiveness Analysis, By Country
Figure 61: Europe Insomnia Treatment Market Attractiveness Analysis, By Drug Type
Figure 62: Europe Insomnia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 63: Asia Pacific Insomnia Treatment Market Value Share (2017A), By Drug Type , Distribution Channel and Country
Figure 64: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
Figure 65: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 66: Asia Pacific Insomnia Treatment Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 67: China Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 68: China Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 69: India Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 70: India Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 71: Japan Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 72: Japan Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 73: Australia & New Zealand Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 74: Australia & New Zealand Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 75: ASEAN Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 76: ASEAN Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 77: Rest of Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 78: Rest of Asia Pacific Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 79: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By OTC Drugs
Figure 80: Asia Pacific Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By OTC Drugs
Figure 81: Asia Pacific Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Drugs
Figure 82: Asia Pacific Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Prescription Drugs
Figure 83: Asia Pacific Insomnia Treatment Market Attractiveness Analysis, By Country
Figure 84: Asia Pacific Insomnia Treatment Market Attractiveness Analysis, By Drug Type
Figure 85: Asia Pacific Insomnia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 86: Middle East and Africa Insomnia Treatment Market Value Share (2017A), By Drug Type , Distribution Channel and Country
Figure 87: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Analysis, 2013-2017
Figure 88: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018-2026
Figure 89: Middle East and Africa Insomnia Treatment Market Y-o-Y growth (%) Comparison, By Country, 2018-2026
Figure 90: GCC Countries Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 91: GCC Countries Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 92: South Africa Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 93: South Africa Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 94: Rest of MEA Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017
Figure 95: Rest of MEA Insomnia Treatment Market Size (US$ Mn) Forecast & Y-o-Y Growth (%), 2018–2026
Figure 96: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By OTC Drugs
Figure 97: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By OTC Drugs
Figure 98: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) Analysis, 2013–2017, By Prescription Drugs
Figure 99: Middle East and Africa Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026, By Prescription Drugs
Figure 100: Middle East and Africa Insomnia Treatment Market Attractiveness Analysis, By Country
Figure 101: Middle East and Africa Insomnia Treatment Market Attractiveness Analysis, By Drug Type
Figure 102: Middle East and Africa Insomnia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 103: Global Insomnia Treatment Market Attractiveness Analysis, By Region
Figure 104: Global Insomnia Treatment Market Attractiveness Analysis, By Drug Type
Figure 105: Global Insomnia Treatment Market Attractiveness Analysis, By Distribution Channel
Figure 106: Global Insomnia Treatment Market Size and Y-o-Y, 2013 - 2017
Figure 107: Global Insomnia Treatment Market Size (US$ Mn) & Y-o-Y Growth (%), 2018–2026
Figure 108: Global Insomnia Treatment Market Absolute $ Opportunity, 2017–2026
